Skip to main content
. 2020 Apr 1;10:10. doi: 10.1038/s41387-020-0111-z

Table 1.

Characteristics of the study participants.

Metabolically healthy individuals (n = 41) Individuals with recently diagnosed diabetes (n = 193) Individuals with a known diabetes duration of ≥5 years (n = 106)
Variables Type 1 diabetes Type 2 diabetes Type 1 diabetes Type 2 diabetes
N (% male) 41 (85) 75 (59) 118 (64) 44 (61) 62 (58)
Age [years] 49.5 ± 12.1 35.9 ± 10.5 52.2 ± 8.8 43.0 ± 13.5 59.7 ± 9.7
BMI [kg/m2] 29.1 ± 5.9 25.2 ± 4.0 32.2 ± 5.7 25.2 ± 2.9 31.5 ± 5.7
Duration since diagnosis of diabetes [months] 6.1 ± 3.0 5.6 ± 3.3 72.0 ± 15.0 74.1 ± 18.3
HbA1c [%] 5.3 ± 0.3 6.3 ± 1.0 6.5 ± 0.9 6.9 ± 1.0 6.9 ± 1.1
HbA1c [mmol/mol] 34 ± 3 45 ± 11 48 ± 10 52 ± 11 52 ± 12
Fasting C-peptide [ng/ml] 2.0 [1.4; 2.5] 0.9 [0.5; 1.3] 3.0 [2.4; 3.9] 0.3 [0.1; 0.8] 2.8 [2.2; 3.9]
Triglycerides [mg/dl] 93 [76; 148] 76 [55; 109] 129 [97; 199] 76 [55; 109] 177 [108; 240]
Total cholesterol [mg/dl] 203 [181; 225] 178 [159; 195] 195 [178; 226] 178 [159; 195] 202 [177; 235]
HDL-cholesterol [mg/dl] 60 [47; 70] 59 [49; 69] 45 [37; 52] 59 [49; 69] 49 [41; 59]
LDL-cholesterol [mg/dl] 133 [108; 150] 105 [87; 124] 132 [107; 156] 105 [87; 124] 128 [106; 158]

Data are n (%), mean ± SD or median (25th; 75th percentile).

HDL high density lipoprotein, LDL low-density lipoprotein.